Epaper KSTORE | KONTAN ACADEMY | PRESSRELEASE.ID | KINERJA EMITEN | MOMSMONEY.ID | KGMEDIA.ID | ADVERTISING
kontan.co.id
banner langganan top
| : WIB | INDIKATOR |
  • EMAS 2.920.000   30.000   1,04%
  • USD/IDR 16.900   45,00   0,27%
  • IDX 7.935   -168,62   -2,08%
  • KOMPAS100 1.117   -23,38   -2,05%
  • LQ45 816   -13,78   -1,66%
  • ISSI 278   -6,99   -2,45%
  • IDX30 426   -6,36   -1,47%
  • IDXHIDIV20 515   -6,10   -1,17%
  • IDX80 125   -2,26   -1,78%
  • IDXV30 139   -2,98   -2,10%
  • IDXQ30 139   -1,10   -0,79%
INDUSTRI /

Menilik prospek bisnis Merck Sharp Dohme Pharma (SCPI)


Senin, 09 Maret 2020 / 17:44 WIB
Menilik prospek bisnis Merck Sharp Dohme Pharma (SCPI)
ILUSTRASI. logo PT Merck Sharp Dohme Pharma Tbk (SCPI)


Reporter: Arfyana Citra Rahayu | Editor: Handoyo

Sebelumnya Selanjutnya



TERBARU
Indeks
Indeks Berita
Kontan Academy
Intensive Sales Coaching: Lead Better, Sell More! Supply Chain Management on Practical Sales Forecasting (SCMPSF)

[X]
×